Celyad SA

CYAD · BR · Healthcare / Biotechnology

0.166EUR-0.00 (-2.35%)

Price History

Full chart

Market Stats

Previous Close0.17

Open0.151

Day Range0.151 – 0.17

52-Week Range0.16 – 0.65

Volume11.40K

Market Cap16.85M

P/E (TTM)11.25

Forward P/E0.00

EPS0.02

Dividend Yield0.00%

Beta1.21

50-Day Avg0.2586

200-Day Avg0.2717

About

Celyad Oncology SA, a biotechnology company, focuses on unlocking the potential of its intellectual property. Its portfolio comprises multiple foundational US patents focused on TCR-deficient T cell compositions, and it broadly covers allogeneic CAR T cell therapies. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Michel E. J. Lussier BME, M.B.A., M.S., MS BME
Employees4
HeadquartersAxis Business Park, Mont-Saint-Guibert, Belgium, 1435, Belgium
Websitehttps://celyad.com

Leadership

Mr. Michel E. J. Lussier BME, M.B.A., M.S., MS BMECo-Founder & Non-Executive Director · b. 1956
Mr. Hannes IserentantGeneral Manager · b. 1978
Mr. David GeorgesVice President of Finance & Administration · b. 1976
Sara ZelkovicCommunications & Investor Relations Director
Ms. An PhanHead of Legal · b. 1975
Mr. Philippe DechampsCorporate Secretary · b. 1970

Financials

Income Statement

Currency: EUR	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	1.52M	26.93K	54.00K	0	146.00K	3.00K	10.01M	3.54M	3.12M	6.00K	5.00K	0	0	102.00K	186.00K	21.00K
Growth (%)	-	-98.22%	+100.50%	-100.00%	-	-97.95%	+333633.33%	-64.64%	-12.01%	-99.81%	-16.67%	-100.00%	-	-	+82.35%	-88.71%
Cost of Revenue	4.15M	5.80M	6.68M	2.42M	115.00K	2.00K	1.54M	515.00K	0	0	0	1.52M	1.44M	69.00K	-733.00K	-1.91M
Gross Profit	-2.64M	-5.77M	-6.63M	-886.00K	31.00K	-1.03M	8.47M	3.02M	3.12M	6.00K	5.00K	-1.52M	-1.44M	33.00K	919.00K	1.93M
Gross Margin	-174.01%	-21428.04%	-12275.93%	-	21.23%	-34366.67%	84.60%	85.45%	100.00%	100.00%	100.00%	-	-	32.35%	494.09%	9195.24%
Operating Expense	6.07M	3.31M	-5.19M	12.07M	16.47M	28.64M	34.08M	55.90M	41.28M	28.89M	16.99M	24.87M	28.03M	10.63M	7.18M	9.11M
Operating Income	-8.71M	-9.08M	-1.44M	-12.95M	-16.44M	-29.67M	-25.61M	-52.88M	-38.17M	-28.88M	-16.99M	-26.39M	-29.47M	-10.60M	-6.26M	-7.18M
Operating Margin	-574.60%	-33725.68%	-2668.52%	-	-11258.22%	-989066.67%	-255.78%	-1493.67%	-1225.36%	-481316.67%	-339740.00%	-	-	-10389.22%	-3365.05%	-34200.00%
EBITDA	-5.53M	-6.36M	-12.00M	-12.07M	-15.56M	-28.07M	-21.99M	-55.70M	-36.25M	-26.51M	-15.73M	-25.41M	-39.70M	-7.76M	-5.39M	-7.01M
EBITDA Margin	-364.64%	-23622.46%	-22227.78%	-	-10658.22%	-935700.00%	-219.61%	-1573.42%	-1163.79%	-441816.67%	-314640.00%	-	-	-7610.78%	-2898.39%	-33380.95%
Net Income	-6.71M	-9.13M	-13.52M	-12.35M	-16.45M	-29.11M	-23.61M	-56.40M	-37.43M	-28.63M	-17.20M	-26.51M	-40.94M	-8.45M	-5.82M	830.00K
Net Income Margin	-442.68%	-33915.05%	-25044.44%	-	-11269.18%	-970466.67%	-235.78%	-1593.08%	-1201.51%	-477200.00%	-344080.00%	-	-	-8282.35%	-3131.18%	3952.38%
R&D	4.02M	4.14M	3.40M	9.05M	15.87M	22.77M	27.68M	22.91M	23.58M	25.23M	21.59M	19.50M	17.70M	4.67M	2.89M	3.28M
R&D as % of Total Revenue	264.97%	15357.20%	6298.15%	-	10866.44%	758866.67%	276.42%	647.12%	756.89%	420533.33%	431820.00%	-	-	4576.47%	1551.61%	15614.29%
Interest Expense	294.76K	33.30K	627.45K	425.42K	22.00K	44.00K	109.00K	144.00K	62.00K	343.00K	297.00K	255.00K	197.00K	84.00K	119.00K	64.00K
Interest Expense % of Total Revenue	19.44%	123.64%	1161.94%	-	15.07%	1466.67%	1.09%	4.07%	1.99%	5716.67%	5940.00%	-	-	82.35%	63.98%	304.76%

Balance Sheet

Currency: EUR	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	17.50M	6.88M	13.75M	32.39M	43.98M	159.53M	138.81M	77.63M	94.30M	89.84M	66.08M	79.94M	19.72M	16.28M	9.93M	4.30M
Total Liabilities	8.80M	6.04M	15.06M	15.49M	17.29M	48.05M	47.92M	30.09M	38.71M	44.22M	35.09M	36.30M	15.40M	9.98M	26.05M	1.86M
Total Equity	8.69M	840.11K	-1.31M	16.90M	26.68M	111.47M	90.88M	47.53M	55.59M	45.62M	30.99M	43.64M	4.32M	6.30M	-16.12M	2.44M
Cash	3.83M	1.75M	1.65M	19.06M	27.63M	100.17M	48.36M	23.25M	40.54M	39.34M	17.23M	30.02M	12.45M	7.00M	4.20M	1.71M
Total Debt	290.97K	116.26K	921.39K	106.37K	413.00K	675.00K	1.48M	1.44M	1.65M	4.36M	3.64M	-12.10M	255.00K	1.06M	17.54M	-
Net Debt	-3.54M	116.26K	-723.64K	-18.95M	-27.22M	-99.50M	-46.88M	-21.81M	-38.90M	-34.98M	-13.60M	-42.12M	-12.19M	-5.95M	13.34M	-1.71M

Cash Flow

Currency: EUR	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-8.32M	-7.63M	-8.34M	-10.64M	-17.41M	-27.30M	-24.69M	-49.55M	-27.25M	-28.20M	-27.66M	-26.64M	-28.01M	-15.20M	-5.68M	-6.90M
Investing Cash Flow	-60.52K	-40.92K	-656.96K	-3.53M	-1.77M	-10.69M	-30.16M	22.72M	607.00K	8.99M	157.00K	-126.00K	7.20M	407.00K	-103.00K	3.01M
Financing Cash Flow	8.78M	5.60M	8.89M	31.58M	27.76M	110.53M	3.03M	605.00K	43.93M	18.28M	5.40M	39.52M	3.24M	9.36M	2.98M	1.39M
Capital Expenditure	45.02K	23.77K	656.96K	531.45K	640.00K	838.00K	1.78M	858.00K	1.76M	622.00K	319.00K	393.00K	123.00K	899.00K	118.00K	0
Free Cash Flow	-8.37M	-7.66M	-8.99M	-11.17M	-18.05M	-28.14M	-26.47M	-50.41M	-29.01M	-28.82M	-27.98M	-27.04M	-28.13M	-16.10M	-5.68M	-6.90M
FCF to OCF	100.54%	100.31%	107.88%	105.00%	103.68%	103.07%	107.22%	101.73%	106.48%	102.21%	101.15%	101.48%	100.44%	105.91%	100.00%	100.00%

Earnings

Report Date	Dec 31, 2013	Aug 26, 2015	Aug 25, 2016	Mar 23, 2017	Aug 29, 2017	Mar 22, 2018	Aug 23, 2018	Mar 28, 2019	Aug 22, 2019	Mar 24, 2020	Aug 6, 2020	Mar 24, 2021	Aug 4, 2021	Mar 24, 2022	Aug 5, 2022	Mar 23, 2023	Sep 4, 2023	Dec 31, 2023	Sep 13, 2024	Dec 31, 2024	Sep 25, 2025	Mar 19, 2026
EPS Estimate	-	-1.64	-1.88	-1.98	-2.86	-1.51	-1.79	-1.68	-1.75	-1.48	-1.19	0.00	-	-0.64	-	-0.62	-0.45	-	-0.59	-	-	-
EPS Actual	-0.93	-0.66	-1.82	-0.72	-1.52	-4.46	-1.81	-1.68	-1.75	-0.95	-1.19	-0.04	-1.09	-0.65	-0.86	-1.19	-0.17	-0.16	-0.12	-0.07	-0.04	0.11
Surprise	-	59.76%	3.19%	63.64%	46.85%	-195.36%	-1.12%	0.00%	0.00%	35.81%	0.00%	-	-	-0.78%	-	-90.98%	63.11%	-	79.95%	-	-	-
Timing	-	Pre-market	-	-	-	-	-	-	-	-	-	-	-	-	Pre-market	After-hours	After-hours	-	-	-	-	-

Key Statistics & Ratios

Market Cap16.85M

Enterprise Value16.94M

Trailing P/E11.25

Forward P/E0.00

Price / Sales2406.96

Price / Book7.65

EPS0.02

Book Value0.028

Revenue (TTM)7.00K

Gross Profit (TTM)235.00K

EBITDA775.00K

Profit Margin47071.43%

Operating Margin13300.00%

Return on Equity56.33%

Return on Assets14.51%

Shares Outstanding74.88M

Shares Float14.16M

Beta1.21

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%